128 related articles for article (PubMed ID: 10102916)
21. Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.
Tsao KC; Liu GH; Chang PY; Lin CN; Wu TL; Sun CF; Wu JT
J Clin Lab Anal; 2001; 15(4):193-8. PubMed ID: 11436202
[TBL] [Abstract][Full Text] [Related]
22. Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors.
Moattari AR; Deftos LJ; Vinik AI
J Clin Endocrinol Metab; 1989 Oct; 69(4):902-5. PubMed ID: 2778040
[TBL] [Abstract][Full Text] [Related]
23. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL
Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366
[TBL] [Abstract][Full Text] [Related]
24. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
Conlon JM
Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
[TBL] [Abstract][Full Text] [Related]
25. Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas.
Børglum T; Rehfeld JF; Drivsholm LB; Hilsted L
Clin Chem; 2007 Mar; 53(3):438-46. PubMed ID: 17259235
[TBL] [Abstract][Full Text] [Related]
26. Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas.
Syversen U; Waldum HL; O'Connor DT
Neuropeptides; 1992 Aug; 22(4):235-40. PubMed ID: 1508327
[TBL] [Abstract][Full Text] [Related]
27. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.
Kidd M; Modlin IM; Mane SM; Camp RL; Shapiro MD
Ann Surg; 2006 Feb; 243(2):273-80. PubMed ID: 16432362
[TBL] [Abstract][Full Text] [Related]
28. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Janson ET
Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of plasma chromogranin A in neuroendocrine tumours.
Tomassetti P; Migliori M; Simoni P; Casadei R; De Iasio R; Corinaldesi R; Gullo L
Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):55-8. PubMed ID: 11204811
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia.
Gleeson CM; Curry WJ; Johnston CF; Buchanan KD
J Endocrinol; 1996 Dec; 151(3):409-20. PubMed ID: 8994386
[TBL] [Abstract][Full Text] [Related]
31. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
33. Cell-specific processing of chromogranin A in endocrine cells of the rat stomach.
Norlén P; Curry WJ; Björkqvist M; Maule A; Cunningham RT; Hogg RB; Harriott P; Johnston CF; Hutton JC; Håkanson R
J Histochem Cytochem; 2001 Jan; 49(1):9-18. PubMed ID: 11118474
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning of chromogranin A from rat pheochromocytoma cells.
Parmer RJ; Koop AH; Handa MT; O'Connor DT
Hypertension; 1989 Oct; 14(4):435-44. PubMed ID: 2793216
[TBL] [Abstract][Full Text] [Related]
35. Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract.
Schürmann G; Raeth U; Wiedenmann B; Buhr H; Herfarth C
World J Surg; 1992; 16(4):697-701; discussion 701-2. PubMed ID: 1413839
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical demonstration of chromogranin A in endocrine organs of the rat and horse by use of region-specific antibodies.
Hashimoto Y; Ohki H; Sato F; Yanaihara N; Iwanaga T
Jpn J Vet Res; 2001 May; 49(1):3-17. PubMed ID: 11521446
[TBL] [Abstract][Full Text] [Related]
37. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
38. Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Woussen-Colle MC; Gourlet P; Vandermeers A; Vandermeers-Piret MC; D'Haens J; Velkeniers B; Robberecht P
Peptides; 1995; 16(2):231-6. PubMed ID: 7784254
[TBL] [Abstract][Full Text] [Related]
39. Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors.
Ferrari L; Seregni E; Lucignani G; Bajetta E; Martinetti A; Aliberti G; Pallotti F; Procopio G; Della Torre S; Luksch R; Bombardieri E
Int J Biol Markers; 2004; 19(4):295-304. PubMed ID: 15646836
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the post-translational processing of chromogranin A in rat neuroendocrine tissue employing an N-terminal site-specific antiserum.
McVicar CM; Cunningham RT; Harriott P; Johnston CF; Buchanan KD; Curry WJ
J Neuroendocrinol; 2001 Jul; 13(7):588-95. PubMed ID: 11442773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
